<DOC>
	<DOCNO>NCT00002555</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . Drugs use chemotherapy use different way stop tumor cell divide stop grow die . It yet know radiation therapy plus chemotherapy effective radiation therapy alone treat patient head neck cancer . PURPOSE : Randomized phase III trial compare effectiveness high-dose radiation therapy alone high-dose radiation therapy plus cisplatin treating patient head neck cancer undergone surgery remove cancer .</brief_summary>
	<brief_title>High-Dose Radiation Therapy With Without Chemotherapy Treating Patients With Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine whether addition cisplatin high-dose postoperative radiotherapy increase disease-free survival rate patient locally advanced head neck carcinoma high risk recurrence follow radical surgery . OUTLINE : Randomized study . Patients register randomized treatment within 25 day surgery . Arm I : Radiotherapy . Irradiation preoperative primary tumor site boost area high risk recurrence use Co60 equipment , 4-6 MV linear accelerator , 6-12 MeV electron . Arm II : Radiotherapy plus Single-Agent Chemotherapy . Irradiation Arm I ; plus Cisplatin , CDDP , NSC-119875 . PROJECTED ACCRUAL : A total 338 evaluable patient study .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm squamous cell carcinoma head neck follow site : Oral cavity Oropharynx Hypopharynx ( ineligible protocol EORTC24891 ) Larynx T34 , N , M0 T , N23 , M0 disease ( UICC stag ) resect curative intent T3 , N0 carcinoma larynx suitable microscopically clear margin ineligible At least one follow highrisk characteristic require : Histopathologically positive surgical margin No gross residual disease Perineural involvement Extranodal spread disease Oral cavity oropharyngeal lesion metastatic node level 4 5 Vascular embolism neck No metastasis diagnosis No known CNS disease PATIENT CHARACTERISTICS : Age : 18 70 Performance status : WHO 02 Hematopoietic : WBC least 4,000 Platelets least 100,000 Hemoglobin normal ( least 6.8 mmoles/liter ) Hepatic : Bilirubin great 2 time normal Other liver function test great 2 time normal Renal : Creatinine great 1.3 mg/dL ( 120 micromoles/liter ) Creatinine clearance great 60 mL/min Other : No active , uncontrolled infection No requirement antibiotic might interfere platinum excretion No requirement drug affect bone marrow function ( e.g. , lithium , corticosteroid ) No medical condition preclude postoperative chemotherapy No prior concurrent malignancy nonmelanomatous skin cancer PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : No prior locoregional radiotherapy head neck Surgery : Excision curative intent require</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
</DOC>